免疫组织化学对恶性淋巴瘤鉴别诊断的意义  

IMMUNOHISTOCHEMICAL METHOD FOR DIFFERENTIAL DIAGNOSIS OF MALGNANT LYMPHOMA

作　　者：陆献瑜[1] 杨毅[1] 

机构地区：[1]中山医科大学肿瘤医院病理科

出　　处：《肿瘤》1991年第1期8-9,共2页Tumor

摘　　要：临床及病理学难免会出现恶性淋巴瘤误诊为癌,或将未分化癌误诊为恶性淋巴瘤的现象;特别对局限鼻咽及扁桃体的肿物活检常规HE切片,呈人为挤压变态时将恶性淋巴瘤误诊为未分化癌的可能性大,因这些部位发生癌比淋巴瘤为多。而两者的治疗方案不同;Six monoclonal antibodies---PD7/26, 2B11, CAM5. 2, 10. 11, CEA and NSE--and ABC immunohistochemical method, were used for studying 85 cases of questionablemalignant lymphomae. The result. demonstrated that 62 cases (72.9%) were malignantlymphomas, 15 cases (17. 6%) were poorly differentiated carcinomas 2 cases (2.4%)were neuroblastomas, and 6 case9 (7.1%) were still in doubt. In conclusion, the 6monoclonal antibodies and ABC method could be of benefit to the differential diagnosisof malignant lymphomas.

关 键 词：免疫组化 恶性 淋巴瘤 诊断 

分 类 号：R733.404[医药卫生—肿瘤]